Which bipolar disorder patients are more likely to receive more than 2 medications, and why? In this video, Dr Goldberg discusses the findings of his recent systematic review focusing on polypharmacy in bipolar disorder.
Vol 87 • 2026 • Number 1
Read the Current Issue
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Meta-Analysis
Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety
Original Research
Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients
Editorial
Thank You to the JCP Community
Editorial
Psychotherapy: Integral to Clinical Psychiatry
Original Research
